Search
13 results for “healthcare”
Banco Safra Resumes Coverage on Bradsaúde, Citing Strong Growth and Dividend Potential
Banco Safra resumed coverage on Bradsaúde (SAUD3), the consolidated healthcare arm of Bradesco, basing its positive outlook on defensive financial results and strong capacity for income generation.
Brazil’s Healthcare Giants Bradsaúde and Rede D’Or Expand Joint Venture into Minas Gerais
The Atlântica D’Or joint venture is investing R$130 million to acquire a stake in Hospital Biocor, marking its first expansion outside São Paulo and Rio de Janeiro.
Brazilian Medical Education Giant AFYA Rises 3.2% on Nasdaq
Brazilian medical education company AFYA, one of the few with a direct US listing, saw its stock rise 3.2% today.
Brazil’s Health Regulator Briefly Suspends Hapvida Premium Hikes, Exposing Sector Volatility
Brazil’s ANS briefly halted Hapvida’s planned premium hikes affecting nearly 1 million policyholders, only to reverse the decision a day later.
Afya Shares Jump as Investors Reconsider Valuation After Strong Brazilian Education Results
Brazilian medical education giant Afya sees its Nasdaq-listed shares climb as investors react to a fundamental performance update.
Afya Shares Jump on Strong Half-Year Results, Driven by Brazil's Demand for Doctors
Brazilian medical education giant Afya, a US-listed stock, posted robust first-half earnings, confirming strong demand for its core service.
Hapvida Targets Higher Margin with NotreDame Saúde Premium Launch
Hapvida (HAPV3) is launching a premium health plan in August under the NotreDame Saúde brand, aiming for margin expansion.
Hapvida Decline Highlights Volatility Across B3 Stocks
Shares of Brazilian healthcare giant Hapvida dropped 5.25% on Monday, diverging from the broader Ibovespa as medical claims anxiety persists.
Hapvida Premium Push Threatens Small-Cap Health Competitors
Hapvida launches its NotreDame Saúde premium brand, shifting from its vertical model and heightening competitive pressure on niche Brazilian healthcare peers.
Viveo Approves R$ 870 Million Capital Increase to Delever
CM Hospitalar (Viveo) approved a capital increase of up to R$ 869.8 million at a deep discount, anchored by the Bueno family's debt conversion.
Viveo Capital Increase: R$ 870 Million Plan to Cut Leverage
Brazilian healthcare distributor Viveo (VVEO3) launches a capital increase of up to R$ 869.76 million to reduce debt and optimize its capital structure.
Viveo Launches R$ 870M Capital Increase to Tackle Debt
Brazilian healthcare distributor Viveo (VVEO3) has approved a private capital increase of up to R$ 869.76 million to reduce leverage and restructure debt.
Small-Cap Stocks Outperform in 2024 Amid Sector Rotation
Small-cap stocks are demonstrating significant outperformance year-to-date, driven by a rotation out of technology and into financials and healthcare.